Navigation Links
Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies
Date:3/10/2009

risk. This successful business strategy enabled BioTrove to expand its own customer base and brand reputation, increasing distribution channels for RapidFire(R) and OpenArray(R) and expanding business.

"BioTrove has been proactive in partnering with scientists and clinicians to enable higher-throughput research leading to advances in healthcare," added Bird. "The company is a blueprint for sound business strategy and demonstrates that quality and a collaborative spirit remain essential characteristics for successful life sciences companies."

In the past year, BioTrove partnered with OSI Pharmaceuticals, the BloodCenter of Wisconsin, and Constellation Pharmaceuticals to assist research efforts with the company's innovative technologies. These research endeavors ranged from lead compound discovery to single nucleotide polymorphism (SNP) genotyping on the OpenArray(R) system to investigating novel therapeutic targets with the RF-MS system. Researchers often appreciate a company that takes interest in research endeavors and provides value-added support to its customers. Ultimately, BioTrove has demonstrated its commitment to enabling research efforts to advance healthcare through strategic customer partnerships.

For exhibiting best practices in growth strategy, BioTrove is an ideal recipient of the Frost & Sullivan 2009 North American Drug Discovery Technologies Growth Strategy Leadership of the Year Award. Each year, Frost & Sullivan presents this award to the company that has demonstrated an exceptional growth strategy within the industry.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance thro
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  Techne Corporation (NASDAQ: ... it has agreed to acquire 100% ownership of ... Inc. (Bionostics).  Bionostics is a global leader in ... that verify the proper operation of in ... point of care blood glucose and blood gas ...
(Date:6/18/2013)... 18, 2013 As a leading ... proudly announces the release of their infographic - ... ". , MeMD's goal was to leverage an ... Health 2.0, Health 3.0 and mHealth.The infographic features ... medical care and the fitness industry in unimaginable ...
(Date:6/18/2013)... June 18, 2013 PathoGenetix, ... system for rapid bacterial strain typing, announced today ... the company as Vice President of Engineering. Dr. ... the company’s RESOLUTION™ Microbial Genotyping System . ... benchtop instrument, pathogen-specific assay kits, database and software, ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Kitware ... today announces a new Fast-Track award from the U.S. ... design-analysis environment (IDAE) for the nuclear power industry. , ... for more than 30 years, but the United States’ ... remarkable gains in power plant utilization through improved refueling, ...
Breaking Biology Technology:Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2
... announced today that the company is proceeding with ... of its heparin sodium injection,multi-dose, single-dose vials and ... recalled nine lots of heparin sodium injection,multi-dose vials ... due to a,higher than usual number of reports ...
... Exclusion Order Barring Importation of CryoCath,s Cryoablation System, ... (Nasdaq:,CRYO), a medical device company focused on the ... filed a formal complaint with the,United States International ... engaged in unfair trade practices by infringing on,several ...
... 28 InterMune, Inc.,(Nasdaq: ITMN ) today ... of InterMune, will present at Susquehanna,s Second Annual,SIGnificant ... March 5, 2008,at 2:30 p.m. EST., To ... investors and other,interested parties may log on to ...
Cached Biology Technology:Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products 2Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products 3CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 3InterMune to Present at the SIGnificant Options in Healthcare Conference 2
(Date:6/18/2013)... lab. At Brandeis University, sophisticated computational models and ... understand the complex interplay between genomic data, virus ... "shell" critical for replication. , ... finding will help researchers alter virus assembly, leaving ... Perlmutter, first author of the scientific paper describing ...
(Date:6/18/2013)... Joshua Obar, Ph.D., Department of Immunology and Infectious ... 2013 ICAAC Young Investigator Award for his research on ... to infection. , Obar earned his B.A. in ... on to complete his Ph.D. in Microbiology and Immunology ... Ph.D. thesis research in Edward Usherwood,s laboratory at the ...
(Date:6/18/2013)... a chemical modification of DNA and this modification ... DNA sequence. Until now, scientists believed that this ... genes. Today, a team of researchers from the ... Dermitzakis, Louis-Jeantet Professor at the Faculty of Medicine, ... and that DNA methylation may play both a ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Joshua Obar 2The secret of DNA methylation 2
... cell surface protein inhibited prostate cancer growth and metastasis ... not respond to hormone therapy, according to a study ... UCLA,s Jonsson Comprehensive Cancer Center. The researchers also ... turned on in prostate cancer that does not respond ...
... biologist Jonathan Brody, Ph.D., assistant professor, Department of ... professor, and member of the Daniel Baugh Institute ... Pathology, Anatomy and Cell Biology at Jefferson Medical ... a W.W. Smith Charitable Trust medical research grant. ...
... "metabolomics" profile of smokers immediately after they had ... cell death, inflammation, and other forms of systemic ... Center, part of Georgetown University Medical Center. ... Ninth AACR Frontiers in Cancer Prevention Research Meeting, ...
Cached Biology News:UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 2UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 3Jefferson researchers receive W.W. Smith Charitable Trust 2Jefferson researchers receive W.W. Smith Charitable Trust 3Studying the metabolome of smokers, Lombardi researchers find early signs of damage 2
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Human Cell Line Slides...
Human Cell Line Slides...
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
Biology Products: